Home › Ovarian Epithelial Carcinoma › NCT05470920

Genetic Testing Decision Aid

Randomized, Controlled Trial of an Electronic Decision Aid for Genetic Testing in Inherited Cancer Syndromes

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* 18 years or older
* Being seen in clinic at Massachusetts General Hospital or Boston Medical Center
* Diagnosed with malignant epithelial ovarian carcinoma or malignant pancreatic adenocarcinoma.

Exclusion Criteria :

* Unable or unwilling to provide informed consent, undergo randomization, or complete the surveys associated with the study
* Previous germline genetic testing
* History of hereditary pancreatitis
* Members of the following vulnerable populations: adults unable to consent, individuals who are not yet adults

About the study

This is a randomized trial to evaluate the effectiveness of an electronic decision aid tool versus a traditional genetic counselor session for multi-gene panel testing for people with ovarian or pancreatic cancer

What is being tested

• Electronic Decision Aid (behavioral)
• Pre-Test Genetic Counseling (behavioral)

Sponsor: Massachusetts General Hospital · Participants: 350 · Started: Oct 14, 2022

Contact the study team

• Daniel C. Chung, MD · Phone: (617) 726-8687
• Danielle A Lynch, BS · Phone: (617) 726-1355

Official record on ClinicalTrials.gov — NCT05470920

Locations in the U.S.

Conditions

• Ovarian Epithelial Carcinoma
• Hereditary Neoplastic Syndromes

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.